Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Moodys
McKesson
Mallinckrodt
US Army
Boehringer Ingelheim
Daiichi Sankyo
Fuji

Generated: May 24, 2018

DrugPatentWatch Database Preview

Taro Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARMS, and what generic alternatives to TARO PHARMS drugs are available?

TARO PHARMS has four approved drugs.

There is one US patent protecting TARO PHARMS drugs.

There are fifteen patent family members on TARO PHARMS drugs in eleven countries.

Summary for Taro Pharms
International Patents:15
US Patents:1
Tradenames:5
Ingredients:4
NDAs:4

Drugs and US Patents for Taro Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms North ACETAMINOPHEN acetaminophen SUPPOSITORY;RECTAL 018337-001 Approved Prior to Jan 1, 1982 OTC Yes Yes ➤ Sign Up ➤ Sign Up
Taro Pharms North INFANTS' FEVERALL acetaminophen SUPPOSITORY;RECTAL 018337-004 Aug 26, 1992 OTC Yes No ➤ Sign Up ➤ Sign Up
Taro Pharms Ireland ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 078014-001 Mar 21, 2008 DISCN No No ➤ Sign Up ➤ Sign Up
Taro Pharms North ACETAMINOPHEN acetaminophen SUPPOSITORY;RECTAL 018337-003 Sep 12, 1983 OTC Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Army
Argus Health
Accenture
US Department of Justice
McKesson
Mallinckrodt
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.